Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465825-11-000017

Options or other derivatives

  • Director bought 40,001,000 shares at $1,000.00 ($1,000,000)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2011-03-31 Purchase : show line 1 in the form Series E Convertible Preferred Stock +1,000 $1,000.00 $1,000,000 $0.03 32,784,623 3,062.5 I
2011-03-31 Purchase : show line 2 in the form Warrants +40,000,000 $0.06 2018-03-30 40,000,000 120,000,000 I
Loading xslF345X03/primary_doc.xml…